Colony Group, LLC
- SEC CIK
- 0001542153
- Latest filing
- Aug 12, 2026
RVPH holding history
Reviva Pharmaceuticals Holdings, Inc. in every 13F filed by Colony Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RVPH overviewAll 13F holders of RVPHFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −2,650−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q4 2025 | 53,000 | $14.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 53,000 | $19.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 53,000 | $20.2K | <0.1% | −7,000−11.7% | Reduced | Holders |
| Q1 2025 | 60,000 | $57.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 60,000 | $108.6K | <0.1% | −101,000−62.7% | Reduced | Holders |
| Q3 2024 | 161,000 | $231.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 161,000 | $206.0K | <0.1% | −10,000−5.8% | Reduced | Holders |
| Q1 2024 | 171,000 | $646.0K | <0.1% | +50,000+41.3% | Added | Holders |
| Q4 2023 | 121,000 | $623.0K | <0.1% | – | No prior filing | Holders |